FTC Clears Caremark/AdvancePCS Deal, Expects Regional PBMs To Serve Small Employers
This article was originally published in The Pink Sheet Daily
Executive Summary
The merger’s completion awaits shareholder approval by both companies, which is expected to occur before the end of March. The combined firm is likely to have increased bargaining power that can be passed on to customers, FTC says.
You may also be interested in...
AmerisourceBergen Will Supply AdvancePCS Mail Pharmacy Six Months Past Merger Completion
AdvancePCS and ABC agree to extend their contract until Sept. 30; Caremark's acquisition of AdvancePCS is expected to close in March. ABC remains pessimistic about retaining the contract beyond September.
Lupus Guidance Suggests Broad Use Of Health-Related Quality Of Life Endpoint
FDA’s draft guidance on systemic lupus erythematosus drug development lists four possible claims that the agency “may be willing to approve”: reduction in disease activity; organ-specific lupus treatment; complete clinical response/remission; and reduction in flares.
RiskMAP Guidance Includes Plans For A Website
FDA is planning to develop a Risk Minimization Action Plan website, an agency risk management guidance states